vitamin bpc 157 Oral BPC-157 Peptide BPC-157 | Vita Bella Health

Store in cool, dry conditions away from direct light exposure

Each produces a different concentration and a different syringe draw volume for the same target dose

BPC-157 was on the FDA 503A Category 2 compounding-restriction list from September 2023 until around April 2026, when it was removed

Causes & What to Do Mounjaro (tirzepatide) is a once-weekly subcutaneous injection prescribed for type 2 diabetes mellitus management in the UK

The compound showed an in vitro NNMT IC 50 of approximately 1.2 M and did not inhibit related methyltransferases at concentrations tested

Manufactured to exceed 99% purity and tested using both HPLC and LC-MS protocols, this peptide is supplied in a sterile, sealed vial to ensure stability and integrity